ClinicalTrials.Veeva

Menu

Prophylactic Tranexamic Acid Versus Adrenaline During Flexible Bronchoscopy (TAVA2)

C

Clinical Hospital Centre Zagreb

Status

Completed

Conditions

Hemoptysis
Bleeding

Treatments

Drug: Adrenaline
Drug: Tranexamic acid
Drug: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT06145191
8.1-23/278-2 02/013AG;

Details and patient eligibility

About

Endobronchial bleeding is a common complication of bronchoscopy. Major bleeding, although rare, can be life threatening and often requires advanced therapeutic interventional pulmonary procedures which are not widely available. Minor bleeding can negatively impact outcomes such as diagnostic yield, sample size and bronchoscopy duration. Both adrenaline and tranexamic acid are successfully used topically for hemostasis during diagnostic bronchoscopy. The aim of this study is to evaluate the efficacy of prophylactically applied adrenaline and tranexamic acid in bleeding prevention during diagnostic bronchoscopy.

Enrollment

1,013 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients undergoing diagnostic bronchoscopy with sampling (including transbronchial biopsy, endobronchial forceps biopsy, brushing, transbronchial needle aspiration)
  • Signed informed consent

Exclusion criteria

  • Any existing contraindication for diagnostic bronchoscopy
  • Coagulopathy (PV INR > 1.3)
  • Thrombocytopenia (<50x10*9 or anemia (Hgb <80 g/L)
  • DOAC, LMWH or antiplatelet drug therapy
  • Thrombophilia, history of pulmonary embolism or deep vein thrombosis
  • Contraindication for endobronchial application of adrenaline
  • Uncontrolled coronary artery disease, cerebrovascular disease or arrhythmia
  • Uncontrolled pulmonary hypertension
  • Cardiovascular decompensation
  • Severe hypoxia (PaO2 <60mmHg, SaO2 <90% with an FiO2 >=60%)

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

1,013 participants in 3 patient groups, including a placebo group

Tranexamic acid
Experimental group
Treatment:
Drug: Tranexamic acid
Adrenaline
Experimental group
Treatment:
Drug: Adrenaline
Placebo
Placebo Comparator group
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

Sonja Badovinac, MD, PhD; Goran Glodic, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems